Impact of Time from Referral to Treatment on Outcomes and Cost of Therapy for Patients Undergoing Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma: An Intention to Treat Analysis

被引：0
|
作者：
Patel, Vivek [1 ]
Baker, Katherine [1 ]
Fishman, Danielle [1 ]
Lessans, Spencer [1 ]
Morris, Trent [1 ]
Dholaria, Bhagirathbhai [1 ]
Jayani, Reena [1 ]
Kassim, Adetola A. [1 ]
Kim, Tae Kon [1 ]
Morgan, David [1 ]
Oluwole, Olalekan O. [1 ]
Savani, Bipin N. [1 ]
Sengsayadeth, Salyka M. [1 ]
Bhaskar, Shakthi [1 ]
机构：
[1] Vanderbilt Univ, Div Hematol Oncol, Med Ctr, Nashville, TN USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-189084
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Chimeric antigen receptor T-cell therapy in rheumatology: B-cell depletion 2.0
    Appalaneni, Rohith
    Achanta, Nikhila
    Mohan, Chandra
    CURRENT OPINION IN RHEUMATOLOGY, 2024, 36 (02) : 126 - 133
  • [32] Pyoderma Gangrenosum Secondary to Chimeric Antigen Receptor T-Cell Therapy for Diffuse Large B-Cell Lymphoma
    Mager, Layna
    Mcfeeters, Jacob
    Plaza, Jose A.
    Dulmage, Brittany
    Kaffenberger, Benjamin H.
    WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2025, 37 (01): : 5 - 7
  • [33] Prognostic impact of peripheral eosinophil counts in patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell therapy
    Dang, Xiuyong
    Ye, Shiguang
    Zhou, Lili
    Lu, Yan
    Li, Ping
    Liang, Aibin
    Qian, Wenbin
    CYTOTHERAPY, 2023, 25 (06) : 573 - 577
  • [34] Cost analysis of patients undergoing allogeneic stem cell transplantation or chimeric antigen receptor T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma from a German healthcare payer perspective
    P. Ahmadi
    S. Ghandili
    F. Jakobs
    C. Konnopka
    A. Morgner-Miehlke
    N. Kröger
    F. Ayuk
    Bone Marrow Transplantation, 2024, 59 : 572 - 574
  • [35] The Impact of Leukapheresis Collection on Patients Undergoing Chimeric Antigen T-Cell Receptor Therapy with Tisagenlecleucel
    Sarkar, Sanila
    Connors, Jeremy S.
    Sheikh, Irtiza
    Rav, Emily
    Wang, Zhongya
    Bassett, Roland L.
    Straubel, Morgan
    Mahadeo, Kris Michael
    Tewari, Priti
    Petropoulos, Demetrios
    Hosing, Chitra
    Ragoonanan, Dristhi
    Khazal, Sajad
    Fucanan, Arthur
    Bibal, Christofer
    BLOOD, 2023, 142
  • [36] Cost analysis of patients undergoing allogeneic stem cell transplantation or chimeric antigen receptor T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma from a German healthcare payer perspective
    Ahmadi, P.
    Ghandili, S.
    Jakobs, F.
    Konnopka, C.
    Morgner-Miehlke, A.
    Kroeger, N.
    Ayuk, F.
    BONE MARROW TRANSPLANTATION, 2024, 59 (04) : 572 - 574
  • [37] Patterns of Use and Impact of Post-Referral and Bridging Therapy on Outcomes in Patients Undergoing CAR T-Cell Therapy for B-Cell Lymphoma: A Single-Center Analysis
    Bhaskar, Shakthi
    Baker, Katherine
    Fishman, Danielle
    Lessans, Spencer
    Dholaria, Bhagirathbhai
    Jayani, Reena
    Kassim, Adetola A.
    Kim, Tae Kon
    Morgan, David
    Oluwole, Olalekan O.
    Savani, Bipin N.
    Sengsayadeth, Salyka
    Patel, Vivek
    BLOOD, 2023, 142
  • [38] Integrating genomic features for prognosis in Chinese patients with B-cell lymphoma following chimeric antigen receptor T-cell therapy
    Linghui Zhou
    Youqin Feng
    Ruimin Hong
    Guoqing Wei
    Mingming Zhang
    Alex HChang
    He Huang
    Yongxian Hu
    Science China(Life Sciences), 2025, 68 (06) : 1703 - 1713
  • [39] Current Challenges in Chimeric Antigen Receptor T-cell Therapy in Patients With B-cell Lymphoid Malignancies
    Kim, Seok Jin
    Yoon, Sang Eun
    Kim, Won Seog
    ANNALS OF LABORATORY MEDICINE, 2024, 44 (03) : 210 - 221
  • [40] Integrating genomic features for prognosis in Chinese patients with B-cell lymphoma following chimeric antigen receptor T-cell therapy
    Zhou, Linghui
    Feng, Youqin
    Hong, Ruimin
    Wei, Guoqing
    Zhang, Mingming
    Chang, Alex H.
    Huang, He
    Hu, Yongxian
    SCIENCE CHINA-LIFE SCIENCES, 2025, : 1703 - 1713
12345